Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease.
Transfer of myelin-specific cells deviated in vitro towards IL-4 production ameliorates ongoing experimental allergic neuritis.
Antibodies to myelin basic protein are associated with cognitive decline after stroke.
Control devices for electrically powered wheelchairs: prevalence, defining characteristics and user perspectives.
Electrodiagnostic studies in presumptive primary hypothyroidism and polyneuropathy in dogs with reevaluation during hormone replacement therapy.
Vitamin D status in patients with MS is negatively correlated with depression, but not with fatigue.
Ocular syphilis in patients with Human Immunodeficiency Virus infection.
The regulator's perspective: How should new therapies and follow-on products for MS be clinically evaluated in the future?
Predictors of static balance in ambulatory persons with multiple sclerosis.
[QUALITY OF LIFE IN CARERS OF PATIENTS WITH MULTIPLE SCLEROSIS TAKING A DISEASE-MODIFYING MEDICATION: A PILOT STUDY].
Distinctive characteristics of early-onset and late-onset neuromyelitis optica spectrum disorders.
Myelitis in systemic lupus erythematosus: clinical characteristics and effect in accrual damage. A single-center experience.
The effects of thrombomodulin and activated protein C on the pathogenesis of multiple sclerosis.
Ultrastructural aspects of mouse nerve-muscle preparation exposed to Bothrops jararacussu and Bothrops bilineatus venoms and their toxins BthTX-I and Bbil-TX: Unknown myotoxic effects.
Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study.
Effect of teriflunomide on QuantiFERON-TB Gold results.
Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex(®).
Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later.
Four-dimensional flow magnetic resonance imaging and ultrasound assessment of cerebrospinal venous flow in multiple sclerosis patients and controls.
Experimental autoimmune encephalomyelitis (EAE): lesion visualization on a 3 Tesla clinical whole-body system after intraperitoneal contrast injection.
The relevance of cortical lesions in patients with multiple sclerosis.
Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies.
N-Truncated Aβ 2-X Starting with Position Two in Sporadic Alzheimer's Disease Cases and Two Alzheimer Mouse Models.
Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
A 17-Year-Old Girl With Acute Onset of Hemiparesis.
Pages
« first
‹ previous
…
724
725
726
727
728
729
730
731
732
…
next ›
last »